"50881-022-08" National Drug Code (NDC)

Jakafi Xr 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08)
(Incyte Corporation)

NDC Code50881-022-08
Package Description30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08)
Product NDC50881-022
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameJakafi Xr
Non-Proprietary NameRuxolitinib
Dosage FormTABLET, EXTENDED RELEASE
UsageORAL
Start Marketing Date20260501
Marketing Category NameNDA
Application NumberNDA217180
ManufacturerIncyte Corporation
Substance NameRUXOLITINIB
Strength22
Strength Unitmg/1
Pharmacy ClassesJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/50881-022-08